Overview
Rybelsus 7 mg is an oral formulation of Semaglutide, a GLP-1 receptor agonist used to manage type 2 diabetes mellitus in adults. It helps improve blood sugar control by enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying. As a once-daily oral medication, Rybelsus provides the benefits of GLP-1 therapy without the need for injections, making it a convenient option for diabetes management.





